scholarly journals Crescentic Glomerulonephritis with Anti-GBM and p-ANCA Antibodies

2012 ◽  
Vol 2012 ◽  
pp. 1-4 ◽  
Author(s):  
Tariq Javed ◽  
Parag Vohra
Keyword(s):  
Renal Failure ◽  
Renal Biopsy ◽  
Recurrence Rate ◽  
Crescentic Glomerulonephritis ◽  
Diagnosis And Treatment ◽  
Atypical Presentation ◽  
Long Term Follow Up ◽  
Pulmonary Renal Syndrome

We are presenting a case of renal failure with anti-GBM and p-ANCA antibodies positive. Patients with dual antibodies are considered to be a vasculitis-variant of anti-GBM antibody nephritis. These patients may have atypical presentation and it may delay diagnosis and treatment. Recurrence rate is higher in these patients. We reviewed the literature of cases and studies on cresenteric glomerulonephritis with anti-GBM and p-ANCA positive patients. We recommend that patients suspected with pulmonary-renal syndrome should be checked for anti-GBM and p-ANCA antibodies, should undergo renal biopsy and should should have close long term follow up to watch for recurrence.

scholarly journals Renal function following acute renal failure in childhood: A long term follow-up study

1989 ◽  
Vol 35 (1) ◽  
pp. 84-89 ◽  
Author(s):  
Helen N. Georgaki-Angelaki ◽  
David B. Steed ◽  
Cyril Chantler ◽  
George B. Haycock
Keyword(s):  
Renal Failure ◽  
Renal Function ◽  
Acute Renal Failure ◽  
Follow Up Study ◽  
Long Term Follow Up

ELECTRO-ANATOMICAL MAPPING SYSTEM REDUCED RECURRENCE RATE OF ISTHMUS DEPENDENT ATRIAL FLUTTER DURING LONG-TERM FOLLOW-UP.

2005 ◽  
Author(s):  
TAKU ASANO ◽  
YOUICHI KOBAYASHI ◽  
TAKAAKI MATSUYAMA ◽  
NORIKAZU WATANABE ◽  
SHUNSHOU RYUU ◽  
...  
Keyword(s):  
Atrial Flutter ◽  
Recurrence Rate ◽  
Mapping System ◽  
Long Term Follow Up

Long-term follow-up after subtotal parathyroidectomy in patients with renal failure

1998 ◽  
Vol 108 (12) ◽  
pp. 1824-1828 ◽  
Author(s):  
Irene Yu ◽  
Maria V. Devita ◽  
Arnold Komisar
Keyword(s):  
Renal Failure ◽  
Subtotal Parathyroidectomy ◽  
Long Term Follow Up

scholarly journals Jeune syndrome with renal failure

2017 ◽  
Vol 145 (3-4) ◽  
pp. 147-152
Author(s):  
Amira Peco-Antic ◽  
Mirjana Kostic ◽  
Brankica Spasojevic ◽  
Gordana Milosevski-Lomic ◽  
Dusan Paripovic ◽  
...  
Keyword(s):  
Renal Failure ◽  
Growth Failure ◽  
Term Survival ◽  
Jeune Syndrome ◽  
Long Term Follow Up ◽  
The University ◽  
Age Range

Introduction/Objective. Jeune syndrome (JS) is a rare hereditary ciliopathy characterized by asphyxiating thoracic dystrophy, shortened limbs and brachydactyly. Extraskeletal anomalies such as chronic renal failure (CRF), hepatic fibrosis, and retinitis pigmentosa may be a part of the JATD phenotype. The aim of this study is to present long-term follow-up of JS patients with early progressive kidney disease. Methods. This is a retrospective study of pediatric patients with JS and CRF who were treated at the University Children?s Hospital between January 1980 and December 2014. The patients? data were retrospectively reviewed from the medical records. Results. There were thirteen patients from 11 families, five girls and eight boys mean aged 4.3 years at the time of diagnosis. All of the patients had characteristic skeletal findings, retinal degeneration and an early onset of CRF at age range from 1.5 to 7 years. Five patients had neonatal respiratory distress and congenital liver fibrosis was diagnosed in five patients. One patient died due to complications of CRF, while others survived during follow-up of mean 11 years. IFT140 mutations were found in four genetically tested patients. Conclusion. The average incidence rate of JS with renal phenotype in Serbia was about 0.2 per one million of child population. Long-term survival of JS patients depends on renal replacement therapy, while skeletal dysplasia, growth failure, respiratory and eyes problems have impact on the patients? quality of life.

scholarly journals Myasthenia gravis and thymus: long-term follow-up screening of thymectomized and non-thymectomized patients

2013 ◽  
Vol 71 (7) ◽  
pp. 462-464 ◽  
Author(s):  
Paulo José Lorenzoni ◽  
Lucas Pires Augusto ◽  
Cláudia Suemi Kamoi Kay ◽  
Rosana Herminia Scola ◽  
Lineu Cesar Werneck
Keyword(s):  
Myasthenia Gravis ◽  
Recurrence Rate ◽  
Progressive Increase ◽  
Clinical Deterioration ◽  
Initial Screening ◽  
Long Term Follow Up ◽  
Study Support ◽  
Anti Acetylcholine

Thymoma screening is recommended at the onset of myasthenia gravis (MG) or when patients with MG present with clinical deterioration or a progressive increase of anti-acetylcholine receptor antibody. However, it is unknown if it is necessary to repeat the screening of thymoma at fixed intervals, even in the absence of MG deterioration, when the initial screening is negative. We analyzed the recurrence rate and incidence of new thymoma in a series of patients with well-controlled MG. The sample consisted of 53 patients, aged 17 to 72 years, and the follow-up varied between 75 and 472 months. The chest computerized tomography detected thymus abnormalities in eight patients at the initial screening and no abnormalities in all patients at a second screening after five years. The findings of this study support the classical opinion that screening for thymoma should be recommended only if there is clinical deterioration due to the disease.

Sign in / Sign up

Export Citation Format

Share Document